Mustafa Nuri Yenerel Selected Research

Thalidomide (Thalomid)

9/2007

Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mustafa Nuri Yenerel Research Topics

Disease

2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 12/2022
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2022 - 03/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2022
1	Vascular Diseases (Vascular Disease) 04/2022
1	Atrial Flutter (Flutter, Atrial) 11/2021
1	Atrial Fibrillation 11/2021
1	Infections 11/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2021
1	Heart Diseases (Heart Disease) 03/2020
1	Lipodystrophy 03/2020
1	Hemorrhage 01/2016
1	Chylous Ascites 10/2012
1	Lymphocytosis 10/2012
1	Neoplasms (Cancer) 09/2012
1	Hemorrhagic Cystitis 12/2009
1	Water Intoxication 12/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2009
1	Exanthema (Rash) 09/2007
1	Constipation 09/2007
1	Leprosy (Hansen's Disease) 09/2007
1	Multiple Myeloma 09/2007
1	Autoimmune Diseases (Autoimmune Disease) 09/2007
1	Tremor (Tremors) 09/2007
1	Erythema elevatum diutinum 09/2007
1	Edema (Dropsy) 09/2007
1	Fatigue 09/2007

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 01/2023 - 03/2017
2	Inosine Triphosphate (ITP)IBA 07/2022 - 03/2017
2	eculizumab FDA Link 04/2022 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2012 - 12/2009
1	Bendamustine Hydrochloride FDA Link 01/2023
1	polatuzumab vedotinIBA 01/2023
1	Biosimilar PharmaceuticalsIBA 12/2022
1	erucylphosphocholineIBA 04/2022
1	acalabrutinibIBA 11/2021
1	ibrutinibIBA 11/2021
1	LeptinIBA 03/2020
1	AutoantibodiesIBA 01/2016
1	ChromatinIBA 10/2012
1	Vincristine (Oncovin)FDA LinkGeneric 10/2012
1	Prednisolone (Predate)FDA LinkGeneric 10/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012
1	Mesna (Coenzyme M)FDA LinkGeneric 12/2009
1	Oxygen (Dioxygen)IBA 12/2009
1	Imatinib Mesylate (Gleevec)FDA Link 10/2009
1	Interferon-alpha (Interferon Alfa)IBA 10/2009
1	Thalidomide (Thalomid)FDA Link 09/2007

Therapy/Procedure

3	Therapeutics 07/2022 - 09/2007
2	Drug Therapy (Chemotherapy) 12/2022 - 10/2012
1	Splenectomy 07/2022
1	Defibrillators (Defibrillator) 03/2020
1	Hematopoietic Stem Cell Transplantation 12/2009